Impact of Fourier Transform Infrared Spectroscopy (FTIRS) in ICUs

Recruiting N/A Interventional Study
Organ Failure, Multiple
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 100
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
900 (estimated)
Sponsor
University Hospital, Caen · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study will assess the impact of FTIRS typing on the spread of ESBL-E in intensive care units

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adult patients hospitalized in ICU * ESBL-E carrier Exclusion Criteria: * none
Contacts

Camille Jeanne-Leroyer

+33(0)231065947

jeanneleroyer-c@chu-caen.fr

CONTACT

Olivier Join-Lambert, MD, PhD

+33(0)231064895

olivier.join-lambert@unicaen.fr

CONTACT